SM

Sabby Management Portfolio holdings

AUM $13M
This Quarter Return
-0.19%
1 Year Return
-26.95%
3 Year Return
-56.43%
5 Year Return
-61.92%
10 Year Return
-71.17%
AUM
$339M
AUM Growth
+$339M
Cap. Flow
+$135M
Cap. Flow %
39.85%
Top 10 Hldgs %
57.87%
Holding
181
New
46
Increased
26
Reduced
25
Closed
28

Top Buys

1
WY icon
Weyerhaeuser
WY
$64.6M
2
TEVA icon
Teva Pharmaceuticals
TEVA
$34M
3
REGN icon
Regeneron Pharmaceuticals
REGN
$8.75M
4
AGN
Allergan plc
AGN
$7.45M
5
SLXP
SALIX PHARMACEUTICALS LTD DEL
SLXP
$5.83M

Top Sells

1
GILD icon
Gilead Sciences
GILD
$11M
2
BPTH
Bio-Path Holdings Inc
BPTH
$8.78M
3
SRPT icon
Sarepta Therapeutics
SRPT
$6.71M
4
XBI icon
SPDR S&P Biotech ETF
XBI
$6.23M
5
TMO icon
Thermo Fisher Scientific
TMO
$4.65M

Sector Composition

1 Healthcare 64.94%
2 Real Estate 19.41%
3 Energy 2.49%
4 Consumer Discretionary 1.61%
5 Communication Services 0.88%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
IONS icon
126
Ionis Pharmaceuticals
IONS
$9.64B
– –
0
– –
IWM icon
127
iShares Russell 2000 ETF
IWM
$66.6B
– –
0
– –
LGND icon
128
Ligand Pharmaceuticals
LGND
$3.25B
– –
0
– –
LLY icon
129
Eli Lilly
LLY
$661B
– –
0
– –
MNKD icon
130
MannKind Corp
MNKD
$1.69B
– –
0
– –
MRK icon
131
Merck
MRK
$210B
– –
0
– –
NBIX icon
132
Neurocrine Biosciences
NBIX
$13.5B
– –
0
– –
NVO icon
133
Novo Nordisk
NVO
$252B
– –
0
– –
OEF icon
134
iShares S&P 100 ETF
OEF
$22.1B
– –
0
– –
OMER icon
135
Omeros
OMER
$284M
– –
-20,000
Closed -$241K
PBYI icon
136
Puma Biotechnology
PBYI
$258M
– –
0
– –
PFE icon
137
Pfizer
PFE
$141B
– –
0
– –
RMTI icon
138
Rockwell Medical
RMTI
$59.6M
– –
0
– –
SPY icon
139
SPDR S&P 500 ETF Trust
SPY
$656B
– –
0
– –
TCRT icon
140
Alaunos Therapeutics
TCRT
$4.51M
– –
-737
Closed -$506K
TMO icon
141
Thermo Fisher Scientific
TMO
$183B
– –
-38,630
Closed -$4.65M
TVTX icon
142
Travere Therapeutics
TVTX
$1.75B
– –
0
– –
UNH icon
143
UnitedHealth
UNH
$279B
– –
0
– –
UTHR icon
144
United Therapeutics
UTHR
$17.7B
– –
0
– –
VRTX icon
145
Vertex Pharmaceuticals
VRTX
$102B
– –
0
– –
XBI icon
146
SPDR S&P Biotech ETF
XBI
$5.29B
– –
-131,235
Closed -$6.23M
XNTK icon
147
SPDR NYSE Technology ETF
XNTK
$1.24B
– –
0
– –
VIRX
148
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
– –
0
– –
BPTH
149
DELISTED
Bio-Path Holdings Inc
BPTH
– –
-828
Closed -$8.78M
DMK
150
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
– –
-868
Closed -$386K
4 5
6
7 8